Published in Science on December 13, 1985
Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke (2009) 6.79
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med (2008) 3.64
Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab (2010) 1.42
Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1. J Neurosci (2008) 1.33
A concerted appeal for international cooperation in preclinical stroke research. Stroke (2013) 1.32
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation. Am J Pathol (2007) 1.28
Successful microbubble sonothrombolysis without tissue-type plasminogen activator in a rabbit model of acute ischemic stroke. Stroke (2011) 1.28
A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin Pharmacother (2010) 1.27
Evolution of the thrombolytic treatment window for acute ischemic stroke. Curr Neurol Neurosci Rep (2010) 1.21
Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development. Transl Stroke Res (2010) 1.17
Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems. Exp Transl Stroke Med (2009) 1.11
Stroke location and brain function in an embolic rabbit stroke model. J Vasc Interv Radiol (2010) 1.07
Nonhuman primate models of stroke for translational neuroprotection research. Neurotherapeutics (2012) 1.05
Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model. J Vasc Interv Radiol (2011) 1.04
Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles? Transl Stroke Res (2011) 1.01
Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation. PLoS One (2014) 1.00
The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab (2010) 0.99
Microbubble-augmented ultrasound sonothrombolysis decreases intracranial hemorrhage in a rabbit model of acute ischemic stroke. Invest Radiol (2011) 0.96
Three variations in rabbit angiographic stroke models. J Neurosci Methods (2012) 0.93
Of mice and men: modelling post-stroke depression experimentally. Br J Pharmacol (2014) 0.93
Relationship between thrombus attenuation and different stroke subtypes. Neuroradiology (2013) 0.93
A surgical model of permanent and transient middle cerebral artery stroke in the sheep. PLoS One (2012) 0.93
Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke. J Neurochem (2010) 0.92
Involvement of Mincle and Syk in the changes to innate immunity after ischemic stroke. Sci Rep (2013) 0.88
Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther (2015) 0.87
Intravenous rt-PA: a tenth anniversary reflection. Surg Neurol (2007) 0.86
Neurological assessment scores in rabbit embolic stroke models. Open Neurol J (2013) 0.84
Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke. Ther Hypothermia Temp Manag (2013) 0.82
Advanced imaging application for acute ischemic stroke. Emerg Radiol (2004) 0.81
Intravenous thrombolytics for ischemic stroke. Neurotherapeutics (2011) 0.81
Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator. Brain Res (2010) 0.81
Improving the translation of animal ischemic stroke studies to humans. Metab Brain Dis (2014) 0.81
Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model. Mol Neurobiol (2015) 0.80
A thromboembolic model for the efficacy and safety evaluation of combined mechanical and pharmacologic revascularization strategies. J Neurointerv Surg (2012) 0.80
Synergistic Effect of AJW200, a von Willebrand Factor Neutralizing Antibody with Low Dose (0.9 mg/mg) Thrombolytic Therapy Following Embolic Stroke in Rabbits. J Neurol Neurophysiol (2013) 0.80
Urgent open embolectomy for cardioembolic cervical internal carotid artery occlusion. Neurosurg Rev (2010) 0.78
Decreased Serum Levels of S-100B Protein Reflect Successful Treatment Effects in a Rabbit Model of Acute Ischemic Stroke. Open Neurol J (2011) 0.78
Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice. PLoS One (2013) 0.78
Variations in the circle of Willis in the New Zealand white rabbit. J Vasc Interv Radiol (2011) 0.78
A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy. Transl Stroke Res (2015) 0.77
Stroke, dementia, and drug delivery. Br J Clin Pharmacol (2004) 0.77
Adenosine diphosphate reduces infarct size and improves porcine heart function after myocardial infarct. Physiol Rep (2013) 0.77
A blinded, randomized study of L-arginine in small clot embolized rabbits. Exp Neurol (2015) 0.77
rLOAD: does sex mediate the effect of acute antiplatelet loading on stroke outcome. Biol Sex Differ (2014) 0.76
The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia. Yale J Biol Med (1987) 0.75
Isoflurane Post-Treatment Improves Outcome after an Embolic Stroke in Rabbits. PLoS One (2015) 0.75
Ischemic stroke: experimental models and reality. Acta Neuropathol (2017) 0.75
Superselective Intra-arterial Thrombolysis for Acute Cardioembolic Stroke in a Child with Idiopathic Dilated Cardiomyopathy. A Case Report. Interv Neuroradiol (2001) 0.75
Thrombolytic therapy for acute stroke. West J Med (1989) 0.75
Melatonin and Nitrones As Potential Therapeutic Agents for Stroke. Front Aging Neurosci (2016) 0.75
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology (2007) 3.56
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol (1992) 3.49
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract (2010) 2.75
Psychiatric morbidity and compulsory admission among UK-born Europeans, Afro-Caribbeans and Asians in central Manchester. Br J Psychiatry (1993) 2.52
The problem of associating coagulase-negative staphylococci with disease. Ann N Y Acad Sci (1965) 2.43
Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology (1989) 2.24
Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg (1981) 2.23
The AKT kinase is activated in multiple myeloma tumor cells. Blood (2001) 2.20
Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med (1990) 2.09
Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology (2005) 2.08
American Academy of Pediatrics. Committee on Adolescence. Contraception in adolescents. Pediatrics (1999) 2.06
Is alignment within 8 prism diopters of orthotropia a successful outcome for infantile esotropia surgery? Arch Ophthalmol (1996) 2.06
Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol (1998) 2.00
Should baseline PSA testing be performed in men aged 40 to detect those aged 50 or less who are at risk of aggressive prostate cancer? S Afr Med J (2011) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Assessment of health needs and willingness to utilize health care resources of adolescents in a suburban population. J Pediatr (1983) 1.90
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90
Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology (2000) 1.88
Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke (1996) 1.86
Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res (1991) 1.86
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Trial of Whooping-cough Vaccine. Br Med J (1945) 1.76
Ampicillin levels in sputum, serum, and saliva. Thorax (1970) 1.73
Rocuronium: high risk for anaphylaxis? Br J Anaesth (2001) 1.72
Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect (2007) 1.72
Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke (2000) 1.71
Blood volume replacement in acute anaphylactic cardiovascular collapse related to anaesthesia. Br J Anaesth (1977) 1.70
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS (1994) 1.70
Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment. Neurology (1991) 1.66
A pilot qualitative analysis of the psychosocial factors which drive young people to decline chlamydia testing in the UK: implications for health promotion and screening. Int J STD AIDS (2010) 1.60
Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke (2004) 1.59
The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK. Int J STD AIDS (2012) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Immunohematologic characteristics of infection-associated cerebral infarction. Stroke (1991) 1.55
Inflammatory myopathy causing pharyngeal dysphagia: a new entity. Ann Otol Rhinol Laryngol (1996) 1.54
Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats : correlation with histopathology. Stroke (2000) 1.52
Atherosclerosis: current concepts on pathogenesis and interventional therapies. Ann Neurol (1989) 1.51
Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol (1978) 1.50
How to analyze binding, enzyme and uptake data: the simplest case, a single phase. Life Sci (1982) 1.49
Nanometal surface energy transfer in optical rulers, breaking the FRET barrier. J Am Chem Soc (2005) 1.48
Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med (1976) 1.46
Does bilateral internal thoracic artery grafting increase surgical risk in diabetic patients? Ann Thorac Surg (1998) 1.45
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med (2010) 1.45
Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect (2007) 1.44
Hypermagnesemic pseudocoma. Arch Intern Med (1993) 1.42
Differential regional vulnerability in transient focal cerebral ischemia. Stroke (1982) 1.39
Bicoronary-pulmonary fistulae with coexistent mitral valve prolapse: a case report and literature review of coronary-pulmonary fistula. Eur Heart J (1994) 1.39
Should syphilis be treated differently in HIV-positive and HIV-negative individuals? Treatment outcomes at a university hospital, Brighton, UK. Int J STD AIDS (2009) 1.39
Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res (1984) 1.39
Unexpected resistance in an African immigrant: lessons for the unwary. Sex Transm Infect (2004) 1.39
Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesis. Arch Intern Med (1990) 1.38
Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke (1996) 1.38
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. Int J STD AIDS (1996) 1.38
Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology (1992) 1.38
Eating disorders in adolescents. A position paper of the Society for Adolescent Medicine. J Adolesc Health (1995) 1.36
Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes. Diabetologia (2004) 1.36
Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes (1982) 1.36
Craniopharyngiomas: a clinical and pathological review. Cancer (1976) 1.35
Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J Clin Invest (1989) 1.35
Maternal factors and low birthweight infants: a comparison of blacks with Mexican-Americans. J Fam Pract (1987) 1.34
Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology (1998) 1.34
Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig. Proc Natl Acad Sci U S A (1983) 1.32
Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes (1998) 1.32
Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke (1996) 1.31
Treating anaphylaxis with sympathomimetic drugs. BMJ (1992) 1.31
CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. HIV Med (2007) 1.30
Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol (1999) 1.30
Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol (1990) 1.29
Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon. J Clin Invest (1976) 1.28
A generic digital imaging and communications in medicine solution for a bidirectional interface between the modality and the radiology information system. J Digit Imaging (1999) 1.27
Secondary decline in apparent diffusion coefficient and neurological outcomes after a short period of focal brain ischemia in rats. Ann Neurol (2000) 1.27
Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc Brain Metab Rev (1993) 1.25
Temporal evolution of ischemic injury evaluated with diffusion-, perfusion-, and T2-weighted MRI. Neurology (2000) 1.25
Spectrum of chronic kidney disease in HIV-infected patients. HIV Med (2009) 1.24
Distribution of biogenic amines and related enzymes in the rat pituitary gland. J Neurochem (1975) 1.24
Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch Neurol (1988) 1.23
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations. HIV Med (2010) 1.23
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. Leukemia (2004) 1.23
Assembly of proteins to postsynaptic densities after transient cerebral ischemia. J Neurosci (1998) 1.22
Kinetics of glucagon in man: effects of starvation. Proc Natl Acad Sci U S A (1976) 1.22
The relation of drinking and smoking habits to diet: the Lipid Research Clinics Prevalence Study. Am J Clin Nutr (1985) 1.21
Surfing with spirochaetes: an ongoing syphilis outbreak in Brighton. Sex Transm Infect (2001) 1.20
Selective necrosis and total necrosis in focal cerebral ischemia. Neuropathologic observations on experimental middle cerebral artery occlusion in the macaque monkey. J Neuropathol Exp Neurol (1984) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men. Sex Transm Infect (2008) 1.19
Transcranial near-infrared light therapy improves motor function following embolic strokes in rabbits: an extended therapeutic window study using continuous and pulse frequency delivery modes. Neuroscience (2007) 1.18
Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes. Neuroscience (2007) 1.18
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Med (2007) 1.17
Reproducibility and reliability of middle cerebral artery occlusion using a silicone-coated suture (Koizumi) in rats. J Neurol Sci (1997) 1.17
Course and outcome of chronic fatigue in children and adolescents. Pediatrics (1998) 1.17